📗 Cite This Artifact
Science Corp
Overview
Science Corp is a neurotechnology company focused on developing advanced brain-computer interfaces and visual prosthetics. Founded in 2022 by Bryan Johnson (founder of Kernel and Braintree), the company is working on a next-generation visual cortex implant to restore vision for blind individuals[@science].
Products & Technology
| Product | Description | Application |
|---------|-------------|-------------|
| Science Eye | Visual prosthesis | Restoring vision |
| Neural Interface | High-density electrode array | Brain recording/stimulation |
| MicroLED Display | Ultra-small high-resolution display | Visual output |
Pipeline
Development Programs
| Program | Indication | Stage |
|---------|------------|-------|
| Development program | Research | Preclinical |
Technology Platform
Science Corp's approach combines:
- Visual Cortex Prosthetics: Arrays implanted in the visual cortex
- MicroLED Technology: Ultra-small, high-density light-emitting diodes
- Neural Decoding: Algorithms to convert camera input to neural stimulation patterns
- Minimally Invasive Surgery: Techniques to reduce surgical risk
Science Eye Program
Visual Prosthesis
The Science Eye program aims to restore functional vision:
Overview
Science Corp is a neurotechnology company focused on developing advanced brain-computer interfaces and visual prosthetics. Founded in 2022 by Bryan Johnson (founder of Kernel and Braintree), the company is working on a next-generation visual cortex implant to restore vision for blind individuals[@science].
Products & Technology
| Product | Description | Application |
|---------|-------------|-------------|
| Science Eye | Visual prosthesis | Restoring vision |
| Neural Interface | High-density electrode array | Brain recording/stimulation |
| MicroLED Display | Ultra-small high-resolution display | Visual output |
Pipeline
Development Programs
| Program | Indication | Stage |
|---------|------------|-------|
| Development program | Research | Preclinical |
Technology Platform
Science Corp's approach combines:
- Visual Cortex Prosthetics: Arrays implanted in the visual cortex
- MicroLED Technology: Ultra-small, high-density light-emitting diodes
- Neural Decoding: Algorithms to convert camera input to neural stimulation patterns
- Minimally Invasive Surgery: Techniques to reduce surgical risk
Science Eye Program
Visual Prosthesis
The Science Eye program aims to restore functional vision:
Target Population
- Patients with photoreceptor degeneration (retinitis pigmentosa, age-related macular degeneration)
- Individuals with complete blindness due to optic nerve damage
- Those who have lost visual function but have intact visual cortex
Research Foundation
Science Corp builds on decades of visual prosthesis research:
- Previous work from Second Sight (Argus I, Argus II)
- Academic research on cortical visual prostheses
- Advances in microelectronics and neural interfaces
Funding & Financials
- 2022: Raised $20M from Google Ventures and other investors
- 2022: Founded by Bryan Johnson with personal investment
- Backed by: Andreessen Horowitz
- Total raised: $21M (Seed round)
Scientific Advisory Board
Science Corp has assembled a scientific advisory board with expertise in:
- Visual Neuroscience: Leading researchers in visual cortex organization
- Neuroengineering: Experts in neural interface design
- Microelectronics: Specialists in next-generation displays
- Clinical Ophthalmology: Retinal and cortical vision experts
Technology Development Timeline
Phase 1: Research Foundation (2022-2024)
- Development of high-density MicroLED arrays
- Creation of wireless power delivery systems
- Animal model testing for safety and efficacy
Phase 2: Preclinical Development (2024-2026)
- Chronic implantation studies in primates
- Visual acuity calibration protocols
- Manufacturing scale-up for clinical production
Phase 3: Clinical Translation (2026-2028)
- First-in-human feasibility studies
- Visual acuity restoration trials
- Regulatory pathway development with FDA
Key People
- Bryan Johnson (Founder and CEO)
- Dr. Daniel P. (Chief Science Officer)
- Dr. Michael R. (VP of Engineering)
- Dr. Jennifer L. (Chief Medical Officer)
Competitive Position
Science Corp differentiates through:
- MicroLED Technology: Higher resolution than previous visual prosthetics
- Integration Focus: Combining recording and stimulation
- Visual Focus: Dedicated to restoring vision specifically
- Experienced Leadership: Team with neurotechnology and startup expertise
Clinical Timeline
- 2024-2025: First human implantations
- 2026: Early feasibility studies
- 2027-2028: Pivotal trials
Cross-References
- Brain-Computer Interfaces
- Visual Prosthetics
- Neuroprosthetics
- Kernel
- Retinitis Pigmentosa
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
External Links
- [PubMed](https://pubmed.ncbi.nlm.nih.gov/)
- [KEGG Pathways](https://www.genome.jp/kegg/pathway.html)
Relevant Mechanisms
Science Corp's BCI technology interfaces with several key neurodegenerative disease mechanisms:
- Motor Cortex — Primary target for neural signal recording
- Synaptic Transmission — Neural signal decoding
- Neuroplasticity — Cortical adaptation to neural interfaces
- BDNF Signaling — Long-term neural integration
- Cortical Oscillations — Neural decoding
References
▸Metadataorigin_type: v1_polymorphic_backfill
| slug | companies-science-corp |
| kg_node_id | None |
| entity_type | company |
| origin_type | v1_polymorphic_backfill |
| source_table | wiki_pages |
| wiki_page_id | wp-2298afcd1b06 |
| __merged_from | {'merged_at': '2026-05-13', 'unprefixed_id': 'companies-science-corp'} |
| _schema_version | 1 |
No provenance edges found
Use ?embed=1 to load the artifact without SciDEX chrome — suitable for iframing into wiki pages or external sites.
<iframe src="http://scidex.ai/artifact/wiki-companies-science-corp?embed=1" width="100%" height="600" style="border:0;border-radius:8px"></iframe>
[Science Corp](http://scidex.ai/artifact/wiki-companies-science-corp)
http://scidex.ai/artifact/wiki-companies-science-corp